PRESCRIPTION DRUG COSTS; Congressional Record Vol. 166, No. 24
(Senate - February 05, 2020)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page S871]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                        PRESCRIPTION DRUG COSTS

  Mr. GRASSLEY. Last night, in the State of the Union Address, 
President Trump called on Congress to put bipartisan legislation to 
lower prescription drug prices on his desk and that he would sign it.
  Here are the facts. The House is controlled by Democrats. The Senate 
requires bipartisanship to get any legislating done. There are only a 
couple of months left before the campaign season will likely impede 
anything from being accomplished in this Congress. So the time to act 
is right now.
  I am calling on my colleagues on both sides of the aisle to get off 
the sidelines and to work with me and Senator Wyden, as President Trump 
already is, to heed the call to action that he gave us last night and 
pass the Prescription Drug Pricing Reduction Act. It is the only 
significant bipartisan bill in town. President Trump, the AARP, and the 
libertarian Cato think tank, to name just a few people involved, have 
all endorsed the bill.
  If you are serious about fulfilling promises to lower drug costs, my 
office door is open, as Senator Wyden's door is open. It is time for 
the Senate to act and to deliver for the American people.
  I yield the floor.
  The PRESIDING OFFICER. The Senator from Oregon.

                          ____________________